venezuelan
equin
enceph
viru
veev
new
world
alphaviru
famili
togavirida
endem
america
veev
positivestrand
rna
viru
transmit
mosquito
natur
present
rodent
reservoir
six
subtyp
categor
geograph
rang
patholog
equin
human
two
epizoot
strain
iab
ic
aros
mutat
among
enzoot
strain
iab
ic
strain
particular
concern
due
increas
rate
morbid
mortal
risk
associ
viral
amplif
potenti
speci
spillov
human
veev
caus
febril
ill
typifi
fever
malais
vomit
case
infect
progress
central
nervou
system
cn
neurolog
symptom
confus
ataxia
seizur
manifest
mortal
rate
among
case
neurolog
symptom
high
children
adult
longterm
neurolog
deficit
often
seen
survivor
outbreak
veev
colombia
venezuela
result
human
case
addit
natur
outbreak
veev
also
concern
bioterror
perspect
grown
high
titer
requir
low
infecti
dose
contain
multipl
serotyp
former
soviet
union
unit
state
previous
weapon
viru
produc
larg
quantiti
defunct
offens
bioweapon
program
current
vaccin
strain
use
hors
highrisk
personnel
howev
due
low
rate
seroconvers
achiev
vaccin
relianc
two
singl
attenu
mutat
consid
unfit
mass
distribut
date
fdaapprov
therapeut
veev
infect
studi
requir
clarif
mechan
associ
underli
pathogenesi
veev
viral
host
transcriptom
studi
provid
wealth
inform
underli
pathogen
mechan
interact
follow
cours
infect
use
highthroughput
nextgener
sequenc
led
discoveri
previous
uncharacter
virus
establish
numer
novel
experiment
system
redefin
virushost
interact
date
number
studi
examin
alter
host
transcriptom
follow
veev
infect
compar
microarray
analysi
cell
persist
infect
veev
cell
abl
clear
veev
result
identif
antivir
factor
molecular
comparison
util
microarray
hostbas
respons
strain
abl
identifi
biomark
differenti
vaccin
respond
vaccin
nonrespond
group
well
involv
interferon
ifn
interferoninduc
pathway
tolllik
receptor
tlr
interleukin
relat
pathway
studi
examin
role
adhes
inflammatori
factor
veevinfect
mice
found
viral
modul
express
extracellular
matrix
adhes
gene
integrin
cadherin
vascular
cell
adhes
molecul
intracellular
adhes
molecul
brain
veevinfect
mice
followup
experi
util
mice
demonstr
reduc
inflamm
brain
subsequ
delay
onset
neurolog
sequela
studi
sharma
et
al
util
microarray
analyz
gene
express
chang
brain
tissu
veevinfect
mice
cours
infect
discov
numer
immun
pathway
involv
antigen
present
inflamm
apoptosi
tradit
antivir
respons
mif
clusterin
major
histocompat
complex
mhc
class
ii
second
studi
group
identifi
regul
microrna
mirna
brain
veevinfect
mice
enabl
correl
mirna
chang
earlier
mrna
express
data
analys
suggest
veev
may
util
cellular
mirna
order
regul
downstream
mrna
may
correspond
veevinduc
histolog
chang
nervou
system
current
studi
nextgener
rna
sequenc
rnaseq
use
identifi
clinic
relev
alter
mrna
transcriptom
human
astrocyt
infect
wildtyp
wt
veev
strain
trinidad
donkey
trd
analysi
host
mrna
rnaseq
provid
novel
insight
host
respond
viral
infect
identif
wide
dynam
rang
transcript
unbias
manner
select
sequenc
mrna
specif
polyadenyl
poli
transcript
account
entir
transcriptom
enhanc
detect
relev
lowabund
transcript
veev
shown
product
infect
astrocyt
vitro
vivo
chose
astrocyt
model
interest
astrocyt
abund
cell
brain
outnumb
neuron
least
provid
abund
resourc
viral
replic
within
brain
addit
welldescrib
structur
role
neuron
tissu
astrocyt
play
critic
role
process
includ
regul
blood
flow
bloodbrain
barrier
synaps
transmiss
respons
infect
veevinfect
astrocyt
shown
produc
multipl
cytokin
includ
interferon
gamma
gamma
interferoninduc
protein
found
associ
viral
attenu
order
obtain
dynam
view
virushost
interactom
rnaseq
use
monitor
chang
gene
express
veev
trdinfect
astrocyt
h
postinfect
hpi
view
alter
multipl
earli
time
point
use
triplic
biolog
replic
robust
dynam
rang
inform
gener
inform
provid
increas
power
accuraci
detect
differenti
express
transcript
highli
relev
clinic
model
among
veevinfect
cell
increas
interferonregul
gene
includ
oasl
observ
increas
express
gene
involv
stressinduc
unfold
protein
respons
upr
pathway
also
note
interestingli
veev
infect
result
increas
earli
growth
respons
protein
may
serv
link
two
pathway
identif
host
mrna
whose
express
alter
follow
veev
replic
specif
interactor
downstream
may
provid
novel
hostbas
therapeut
target
critic
veev
replic
greater
understand
underli
mechan
underpin
alphaviru
replic
veev
trd
obtain
bei
resourc
experi
veev
trd
perform
biosafeti
level
condit
work
involv
select
agent
regist
center
diseas
control
prevent
conduct
georg
mason
univers
biomed
research
laboratori
regist
accord
feder
select
agent
regul
infect
veev
ad
supplement
dulbecco
modifi
eagl
medium
dmem
achiev
multipl
infect
moi
cell
infect
h
rotat
everi
min
ensur
adequ
coverag
cell
wash
phosphatebuff
salin
pb
complet
growth
medium
ad
back
cell
viral
supernat
cell
collect
variou
time
postinfect
analysi
plaqu
assay
perform
previous
describ
rna
cell
purifi
veev
trdinfect
biosafeti
level
mockinfect
cell
hpi
util
mirvana
isol
kit
life
technolog
qualiti
control
purifi
rna
perform
use
agil
bioanalyz
rna
integr
number
rin
cutoff
util
sampl
extern
rna
control
consortium
ercc
rna
spikein
control
mix
ad
total
rna
input
rna
poli
select
use
life
technolog
dynabead
mrna
direct
kit
prepar
wholetranscriptom
rna
librari
purifi
mrna
perform
use
ion
total
rnaseq
kit
life
technolog
qualiti
control
cdna
librari
perform
use
agil
bioanalyz
along
steril
test
remov
librari
sequenc
laboratori
librari
templat
prepar
perform
one
touch
platform
life
technolog
nextgener
rna
sequenc
perform
ion
torrent
pgm
platform
carri
sampl
assess
differenti
gene
express
infect
versu
uninfect
cell
time
total
million
sequenc
read
averag
million
read
per
sampl
use
input
analysi
pipelin
unless
otherwis
note
downstream
rnaseq
analysi
carri
use
clc
bio
genom
workbench
raw
rnaseq
read
trim
remov
residu
sequenc
adapt
fragment
remain
end
sequenc
addit
end
trim
read
done
use
modifi
mott
algorithm
qualiti
score
read
less
bp
discard
follow
read
trim
read
map
human
genom
follow
rnaseq
paramet
limit
multipl
map
posit
similar
fraction
length
fraction
mismatch
cost
indel
cost
express
level
individu
gene
transcript
calcul
use
number
read
per
kilobas
exon
model
per
million
map
read
rpkm
method
mortazavi
et
al
addit
unmap
read
also
map
synthet
rna
sequenc
set
well
veev
refer
genom
genbank
access
number
sampl
correl
coeffici
expect
map
number
read
spikein
control
summari
overal
sequenc
result
shown
tabl
postmap
filter
rnaseq
data
carri
next
includ
gene
least
one
uniqu
map
read
gene
remain
across
data
set
nonzero
interquartil
rang
across
entir
experi
princip
compon
analysi
result
filter
data
set
gene
total
carri
use
raw
count
uniqu
map
read
see
fig
remain
rpkm
express
valu
gene
includ
filter
data
set
subject
quantil
normal
cutoff
box
plot
rpkm
valu
sampl
normal
shown
fig
valu
pairwis
sampletosampl
variat
within
biolog
replic
set
observ
rang
indic
biolog
replic
consist
show
strong
bia
data
shown
differenti
express
gene
deg
identifi
use
two
approach
first
empir
analysi
differenti
gene
express
algorithm
part
edger
bioconductor
packag
appli
integr
data
set
experi
use
default
paramet
fals
discoveri
ratecorrect
p
valu
time
point
infect
mockinfect
sampl
compar
gene
whose
express
differ
signific
p
valu
provision
consid
differenti
express
addit
method
describ
orthogon
statist
test
differenti
express
appli
data
use
statist
test
develop
baggerli
et
al
count
number
express
sequenc
tag
associ
individu
gene
common
featur
serial
analysi
gene
express
sage
data
rnaseq
data
infect
mockinfect
sampl
compar
individu
gene
provision
consid
differenti
express
express
differ
signific
p
valu
differenti
express
gene
found
intersect
set
gene
identifi
method
outlin
consid
highqual
candid
use
start
point
investig
filter
normal
express
data
subject
kmean
cluster
use
euclidian
distanc
metric
gene
group
mean
normal
gene
express
rpkm
valu
experiment
condit
cluster
fit
distinct
cluster
group
individu
gene
express
profil
cluster
test
enrich
gene
ontolog
go
term
associ
individu
gene
gene
annot
obtain
reactom
databas
biolog
pathway
gene
function
annot
enrich
analysi
perform
use
two
approach
first
hypergeometr
test
go
annot
carri
use
implement
gostat
packag
individu
cluster
obtain
kmean
cluster
addit
gene
set
enrich
analysi
gsea
carri
entir
filter
data
set
use
permut
duplic
remov
analysi
varianc
appli
total
categori
pass
minimum
featur
size
use
investig
cohort
gene
share
pattern
express
time
identifi
kmean
cluster
found
enrich
deg
subsequ
subject
pathway
analysi
use
genemania
system
use
ad
hoc
manual
approach
relev
pathway
connect
identifi
basi
exist
data
literatur
coupl
tempor
gene
express
data
obtain
studi
purifi
mrna
convert
cdna
use
highcapac
rnatocdna
kit
life
technolog
accord
manufactur
instruct
analysi
viral
copi
number
perform
quantit
revers
transcriptionpcr
qrtpcr
previous
describ
host
express
follow
gene
assay
taqman
assay
indic
parenthes
activ
transcript
factor
cebpb
cebpd
fo
jun
oasl
xiap
assay
rrna
use
normal
assay
perform
accord
manufactur
instruct
use
abi
stepon
plu
instrument
cell
pretreat
h
protein
kinas
rnalik
endoplasm
reticulum
er
kinas
perk
inhibitor
perki
catalog
number
emd
millipor
dimethyl
sulfoxid
dmso
dmem
prior
infect
veev
trd
moi
h
viral
inoculum
remov
cell
wash
steril
pb
medium
replac
medium
contain
inhibitor
dmso
hpi
medium
remov
cell
wash
pb
collect
western
blot
analysi
cell
seed
cell
per
well
plate
transfect
nm
sigenom
smartpool
catalog
number
dharmacon
allstar
negativecontrol
small
interf
rna
sirna
catalog
number
qiagen
use
dharmacon
dharmafect
transfect
reagent
catalog
number
h
posttransfect
cell
infect
veev
trd
moi
h
infect
medium
replac
fresh
medium
h
infect
supernat
cell
collect
analysi
protein
lysat
prepar
western
blot
analysi
perform
previous
describ
primari
antibodi
follow
use
antibodi
catalog
number
cell
signal
polyclon
antivenezuelan
equin
enceph
viru
subtyp
iab
capsid
protein
bei
resourc
chop
antibodi
catalog
number
cell
signal
phosphoryl
subunit
eukaryot
initi
factor
antibodi
catalog
number
cell
signal
antibodi
catalog
number
cell
signal
activ
caspas
antibodi
catalog
number
cell
signal
horseradish
peroxidaseconjug
catalog
number
abcam
cell
grown
coverslip
plate
infect
veev
trd
describ
wash
pb
without
ca
mg
fix
formaldehyd
cell
permeabil
triton
pb
min
wash
twice
pb
cell
block
min
room
temperatur
bovin
serum
albumin
pb
primari
antibodi
consist
veev
capsid
protein
catalog
number
bei
resourc
dilut
antibodi
antibodi
catalog
number
cell
signal
dilut
incub
fresh
block
buffer
h
wash
time
min
time
mm
nacl
triton
alexa
fluor
donkey
antigoat
secondari
antibodi
catalog
number
invitrogen
alexa
fluor
donkey
antimous
secondari
antibodi
catalog
number
invitrogen
dilut
use
secondari
antibodi
treat
manner
primari
antibodi
dapi
dilut
use
visual
nuclei
coverslip
mount
onto
glass
slide
use
fluoromount
g
mount
medium
catalog
number
southern
biotech
nikon
eclips
fluoresc
microscop
use
fluoresc
microscopi
imag
view
use
object
oil
immers
len
five
imag
sampl
obtain
repres
imag
sampl
shown
imag
subject
fourlin
averag
imag
process
nikon
nisel
ar
analysi
softwar
wildtyp
mous
embryon
fibroblast
mef
infect
trd
variou
moi
hour
wash
pb
medium
replac
cell
viabil
measur
h
postinfect
use
promega
celltit
luminesc
cell
viabil
assay
catalog
number
accord
manufactur
protocol
luminesc
read
use
beckman
coulter
dtx
multimod
detector
integr
time
ms
per
well
similarli
caspas
activ
infect
wildtyp
mef
measur
h
postinfect
use
promega
caspas
glo
assay
catalog
number
accord
manufactur
protocol
luminesc
read
use
dtx
multimod
detector
integr
time
ms
per
well
raw
sequenc
data
rnaseq
run
includ
work
public
avail
ncbi
bioproject
databas
access
number
http
veev
replic
vivo
monocyt
macrophag
neuron
astrocyt
common
cell
line
use
studi
veev
infect
includ
vero
bhk
cell
studi
astrocyt
chosen
vitro
model
due
physiolog
relev
greater
clinic
signific
initi
experi
perform
character
viral
replic
cell
veev
replic
kinet
cell
measur
use
plaqu
assay
monitor
viral
protein
rna
express
level
cytopath
effect
cpe
infect
cell
fig
viral
releas
observ
earli
hpi
log
unit
viru
observ
follow
consist
increas
replic
hpi
fig
viral
replic
peak
hpi
addit
increas
viral
titer
observ
hpi
viral
capsid
express
follow
similar
pattern
protein
detect
hpi
express
plateau
hpi
fig
among
infect
cell
signific
cpe
observ
microscopi
hpi
littl
cpe
detect
hpi
data
shown
consist
observ
increas
caspas
activ
observ
hpi
fig
basi
data
time
hpi
reflect
earli
middl
late
stage
viral
life
cycl
respect
select
rnaseq
analysi
order
provid
dynam
view
hostpathogen
transcriptom
profil
mrna
triplic
set
mock
veevinfect
cell
cultur
isol
purifi
hpi
use
prepar
cdna
librari
downstream
rnaseq
see
materi
method
highlevel
summari
rnaseq
result
shown
tabl
veev
rna
sampl
assay
quantit
rtpcr
time
point
control
demonstr
increas
viral
rna
load
time
fig
consist
increas
number
rnaseq
read
map
veev
genom
later
time
point
tabl
rnaseq
analysi
individu
gene
express
number
read
per
kilobas
exon
model
per
million
map
read
rpkm
rpkm
express
valu
experiment
sampl
shown
fig
found
data
set
supplement
materi
minim
sampletosampl
variat
express
valu
within
biolog
replic
consist
detect
replic
data
shown
addit
intersampl
variat
also
found
minim
test
pairwis
across
entir
experi
use
rpkm
valu
synthet
spikein
control
rna
comparison
data
shown
anticip
twocompon
princip
compon
analysi
rnaseq
data
mockinfect
cell
versu
veevinfect
cell
show
clear
separ
sampl
hpi
sampl
earlier
time
point
fig
howev
cluster
veevinfect
sampl
mockinfect
sampl
earlier
time
point
suggest
respons
viral
infect
limit
narrow
subset
earli
respons
gene
thu
place
higher
burden
proof
identifi
differenti
express
gene
deg
first
hour
infect
along
line
two
orthogon
method
use
identifi
deg
suitabl
character
edger
method
method
develop
baggerli
et
al
gene
identifi
one
method
provision
consid
deg
identifi
method
candid
deg
confirm
qrtpcr
addit
compar
individu
gene
express
valu
mockinfect
cell
veevinfect
cell
time
point
gene
express
valu
also
compar
serial
within
time
seri
veevinfect
cell
gene
show
statist
signific
chang
express
mockinfect
cell
schemat
compar
analysi
shown
fig
number
statist
signific
deg
identifi
comparison
shown
fig
furthermor
kmean
cluster
normal
rpkm
valu
employ
identifi
gross
chang
gene
express
time
cohort
gene
potenti
share
pathway
regulatori
trigger
fig
see
also
data
set
supplement
materi
gene
set
enrich
analysi
gsea
see
materi
method
data
set
supplement
materi
carri
kmean
cluster
particular
cluster
tabl
significantli
enrich
gene
involv
translat
control
type
interferonmedi
signal
pathway
unfold
protein
respons
upr
pathway
gsea
p
valu
although
wellestablish
connect
translat
control
upr
novel
connect
upr
type
interferonmedi
respons
respons
viral
replic
suggest
pathway
analysi
see
materi
method
implic
earli
growth
respons
potenti
bridg
two
pathway
fig
belong
cluster
strongli
induc
veev
infect
sever
gene
associ
interferon
respons
belong
cluster
associ
increas
express
activ
transcript
factor
key
compon
upr
also
belong
cluster
connect
repres
potenti
bridg
upr
pathway
interferon
respons
pathway
one
potenti
key
transcript
factor
drive
connect
consequ
gene
analysi
select
character
qrtpcr
see
activ
transcript
factor
cebpb
cebpd
fo
jun
oasl
express
valu
gene
measur
rnaseq
shown
fig
b
confirmatori
qrtpcr
analysi
indic
concord
gene
express
fig
interferon
respons
gene
induc
agreement
detect
previous
publish
studi
gene
serv
intern
posit
control
moreov
link
interferon
pathway
demonstr
induc
mous
fibroblast
human
fibroblast
upr
pathway
select
analysi
role
veev
infect
elucid
rnaseq
pathway
analysi
data
indic
upr
stress
respons
gene
induc
veev
infect
infect
host
cell
respond
cellular
stress
result
increas
viral
protein
translat
secret
trigger
onset
upr
pathway
upr
pathway
adapt
cellular
respons
activ
endoplasm
reticulum
er
stress
due
protein
misfold
order
regul
cellular
homeostasi
protein
fold
secret
upr
pathway
develop
three
class
sensor
ensur
proper
cellular
regul
inositolrequir
enzym
protein
kinas
rnalik
er
kinas
perk
activ
transcript
factor
veev
infect
perk
arm
upr
appear
alter
two
critic
regul
pathway
differenti
express
chop
determin
deg
alter
subsequ
protein
express
western
blot
analysi
perform
chop
phosphoryl
tunicamycin
glycosyl
inhibitor
induc
upr
includ
posit
control
time
cours
analysi
cell
treat
tunicamycin
indic
h
treatment
provid
robust
induct
upr
protein
data
shown
veevinfect
mockinfect
uvinactiv
veev
uvveev
infect
cell
display
dramat
increas
express
modest
consist
increas
chop
express
hpi
fig
chang
protein
express
observ
hpi
data
shown
confoc
microscopi
confirm
chop
upregul
demonstr
robust
nuclear
stain
pattern
veevinfect
cell
mockinfect
cell
fig
e
protein
express
level
increas
mrna
abund
decreas
follow
veev
infect
fig
result
consist
observ
express
regul
translat
level
upon
upr
induct
phosphoryl
multipl
kinas
perk
protein
kinas
doublestrand
rna
depend
pkr
gener
control
hemeregul
inhibitor
hri
perk
inhibitor
perki
use
determin
observ
phosphoryl
perk
depend
treatment
veevinfect
cell
perki
result
mark
decreas
phosphoryl
fig
result
indic
perk
contribut
phosphoryl
like
addit
kinas
contribut
phosphoryl
event
collect
find
indic
perk
arm
upr
pathway
induc
later
time
point
follow
veev
infect
transcript
factor
induc
numer
signal
includ
oxid
stress
hypoxemia
growth
factor
also
activ
upon
infect
dna
rna
virus
includ
epsteinbarr
viru
mous
hepat
viru
murin
coronaviru
japanes
enceph
viru
treatment
mef
upr
activ
thapsigargin
shown
induc
express
perkdepend
manner
given
link
upr
robust
induct
mrna
express
follow
veev
infect
fig
chosen
studi
protein
express
veev
infect
analyz
western
blot
analysi
previou
studi
indic
activ
mous
hepat
viru
independ
viru
replic
like
due
cellular
membran
disrupt
follow
entri
uvinactiv
viru
control
uvveev
includ
protein
level
increas
follow
veev
infect
compar
mockinfect
cell
uvveevinfect
cell
fig
compar
lane
dramat
upregul
occur
hpi
correl
highest
level
veev
capsid
product
fig
follow
induct
shown
transloc
nucleu
induc
gene
express
bind
egr
bind
sequenc
eb
gcg
gt
ggcg
confoc
microcopi
reveal
high
level
nuclei
infect
cell
wherea
low
level
nuclear
cytoplasm
detect
mockinfect
cell
fig
perki
treatment
veevinfect
cell
result
complet
loss
induct
fig
indic
induc
perkdepend
fashion
result
demonstr
protein
level
nuclear
local
increas
follow
veev
infect
induct
depend
perk
influenc
cell
surviv
apoptosi
impact
veevinduc
cell
death
assess
caspas
cleavag
observ
wt
mef
hpi
infect
moi
start
earli
hpi
infect
moi
fig
contrast
cell
show
littl
detect
caspas
cleavag
follow
infect
veev
two
set
experi
perform
quantit
confirm
result
celltit
glo
assay
measur
total
cell
viabil
atp
product
caspas
glo
assay
measur
caspas
activ
wt
mef
display
dosedepend
decreas
cell
viabil
follow
veev
infect
cell
significantli
viabl
cell
moi
examin
fig
concordantli
dosedepend
increas
caspas
activ
observ
follow
veev
infect
cell
demonstr
reduc
caspas
activ
moi
fig
result
replic
cell
transfect
sirna
target
fig
shown
neg
regul
transcript
survivin
inhibitor
apoptosi
iap
famili
member
rnaseq
data
indic
gene
express
decreas
follow
veev
infect
fold
chang
valu
normal
gene
express
hpi
respect
see
tabl
supplement
materi
ncbi
bioproject
access
number
wt
mef
use
determin
influenc
gene
express
follow
veev
infect
express
significantli
decreas
hpi
veevinfect
wt
mef
reduct
observ
veevinfect
mef
fig
express
gene
xlink
inhibitor
apoptosi
xiap
anoth
iap
famili
member
significantli
differenti
alter
infect
data
shown
collect
result
demonstr
contribut
veevinduc
apoptosi
veev
replic
kinet
determin
wt
mef
determin
relev
viral
replic
cell
infect
two
differ
moi
viral
supernat
collect
hpi
analyz
plaqu
assay
replic
kinet
similar
wt
mef
moi
titer
peak
hpi
fig
lack
express
confirm
western
blot
fig
result
replic
cell
transfect
sirna
target
transfect
sirna
target
result
decreas
protein
express
fig
without
signific
effect
viral
replic
fig
result
suggest
decreas
apoptosi
observ
mef
due
alter
veev
replic
kinet
despit
recogn
emerg
threat
rel
littl
known
virul
mechan
alphavirus
larg
due
knowledg
gap
hostpathogen
interactom
veev
infect
often
result
fatal
enceph
known
inhibit
cellular
transcript
translat
order
downregul
innat
immun
respons
contrast
cn
veev
shown
upregul
numer
gene
inflammatori
respons
apoptot
pathway
specif
numer
proinflammatori
cytokin
includ
glycogen
synthas
kinas
induc
nitric
oxid
synthas
tumor
necrosi
factor
alpha
shown
play
role
veev
pathogenesi
use
highthroughput
nextgener
sequenc
technolog
rnaseq
allow
indepth
unbias
look
virushost
transcriptom
thu
enabl
chang
express
specif
mrna
connect
phenotyp
outcom
end
identif
critic
differenti
express
transcript
among
clinic
relev
infect
cell
help
lead
greater
understand
viral
pathogenesi
may
prove
benefici
identif
therapeut
target
studi
network
analysisrnaseq
data
result
protein
express
studi
reveal
veev
infect
result
activ
perk
arm
upr
pathway
includ
activ
chop
phosphoryl
sever
alphavirus
previous
report
hijack
key
compon
upr
pathway
order
promot
viral
replic
relianc
envelop
virus
er
synthesi
viral
envelopeassoci
glycoprotein
transport
plasma
membran
often
stress
er
due
rapid
viral
protein
product
modul
upr
uniqu
alphavirus
rather
share
trait
mani
positivesens
rna
virus
dengu
viru
shown
suppress
perk
inhibit
continu
phosphoryl
order
inhibit
immedi
apoptosi
increas
viral
protein
translat
extend
length
product
viral
replic
studi
hepat
e
viru
hev
demonstr
express
hev
capsid
protein
open
read
frame
activ
express
chop
hev
shown
stimul
chop
er
stressor
amino
acid
respons
element
aar
interact
result
shown
indic
veev
infect
initi
upr
pathway
subsequ
activ
play
role
outcom
virusinduc
apoptosi
initi
detect
er
stress
perk
abl
identifi
misfold
protein
lumen
er
phosphoryl
order
initi
prosurviv
pathway
upr
gener
inhibit
protein
synthesi
veev
appear
induc
upr
promot
increas
phosphoryl
result
translat
inhibit
mrna
upr
select
increas
translat
respons
express
gene
encod
protein
involv
apoptosi
redox
process
amino
acid
metabol
er
chaperon
recruit
wellknown
mediat
perk
pathway
chop
chop
activ
facilit
increas
express
cellular
chaperon
order
counteract
buildup
misfold
protein
failur
suppress
protein
misfold
persist
stress
cell
viral
infect
result
activ
proapoptot
transcript
factor
chop
lead
suppress
antiapoptot
protein
b
cell
chop
also
function
prosurviv
transcript
factor
dephosphoryl
activ
dna
damageinduc
protein
selfregul
feedback
look
howev
data
present
support
model
wherebi
veev
infect
lead
chop
function
proapoptot
role
chang
gene
express
detect
rnaseq
analysi
upr
induc
follow
veev
infect
robust
activ
observ
later
time
point
infect
somewhat
surpris
veev
infect
expect
induc
signific
er
stress
due
massiv
product
viral
protein
cours
acut
robust
infect
structur
protein
veev
translat
viral
subgenom
rna
polyprotein
rough
er
precursor
glycoprotein
assembl
heterodim
er
undergo
conform
chang
requir
numer
chaperon
possibl
veev
develop
mechan
subvert
induct
upr
order
counteract
upr
nonstructur
protein
nsp
chikungunya
viru
chikv
shown
inhibit
express
known
upr
target
gene
includ
chop
nsp
activ
chikv
develop
mean
suppress
upr
activ
result
viral
glycoproteininduc
er
stress
thu
prevent
immedi
autophagi
apoptot
activ
veev
capsid
respons
interf
nucleocytoplasm
traffick
inhibit
rrna
mrna
transcript
implic
regul
type
ifn
signal
antivir
respons
regul
viral
rna
protein
product
therefor
hypothes
abil
veev
capsid
inhibit
cellular
transcript
block
nucleocytoplasm
traffick
result
delay
induct
upr
result
detail
network
analysi
base
exist
data
literatur
coupl
tempor
gene
express
profil
obtain
studi
point
toward
import
node
novel
link
veev
activ
type
interferon
respons
upr
known
form
dna
bind
complex
cebpb
critic
dimer
partner
chop
previou
studi
demonstr
nuclear
local
chop
may
act
induc
chop
may
act
transcript
cofactor
regul
target
gene
result
western
blot
microscopi
analysi
present
studi
support
model
veev
infect
found
increas
overal
level
nuclear
distribut
chop
along
previou
studi
demonstr
mrna
induct
mous
fibroblast
human
fibroblast
also
known
zinc
finger
protein
mammalian
transcript
factor
implic
cellular
prolifer
differenti
may
also
proapoptot
function
depend
cell
type
stimulu
particular
interest
directli
control
prolifer
activ
mitogenactiv
protein
kinaseextracellular
signalregul
kinas
pathway
mitogenstimul
astrocyt
virusinduc
chang
express
observ
sever
vitro
system
astrocyt
upregul
found
induc
tat
transactiv
promot
lead
cellular
dysfunct
tatinduc
neurotox
increas
amount
mrna
also
demonstr
act
regionspecif
manner
correspond
tempor
viral
rna
product
brain
tissu
rat
infect
either
rabi
viru
borna
diseas
viru
summari
current
studi
demonstr
potenti
link
upr
activ
mef
demonstr
lower
level
suscept
veevinduc
cell
death
wildtyp
mef
indic
modul
proapoptot
pathway
follow
infect
studi
way
determin
alter
upr
small
molecul
inhibitor
sirna
interfer
influenc
veev
replic
andor
cell
death
date
mechan
underli
veev
pathogenesi
subsequ
neuron
degener
partial
elucid
therefor
determin
role
upr
may
play
signific
role
develop
novel
therapeut
target
result
decreas
neuron
death
subsequ
neuron
sequela
result
infect
